Factors to watch | Reuters

August 27, 2015 5:54 AM

24 0

The Swiss flavours and fragrance maker on Thursday cut its five-year organic sales growth target to 4 to 5 percent from its previous target of 4.5 to 5.5 percent. The Geneva-based firm said it would target 12 to 17 percent free cash flow as a percentage of sales by 2020, from the 14 to 16 percent target set for 2015.

The Swiss drugmaker says a combination of its Cotellic and Zelboraf medicines were approved in Switzerland for the treatment of patients with advanced melanoma.

Also watch: Raiders' Derek Carr signs new five-year deal worth $125 million

Read more

To category page